All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is an independent medical education platform. This activity is supported by an educational grant from Lilly. The funders are allowed no direct influence on our content.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View psoriasis and psoriatic arthritis content recommended for you
The Psoriasis and Psoriatic Arthritis Hub was pleased to speak with Peter van de Kerkhof, Radboud University, Nijmegen, NL. We asked, What is teledermatology and does it have a place in the management of psoriasis?
What is teledermatology and does it have a place in the management of psoriasis?
In this interview, van de Kerkhof outlines the drivers for the development of telemedicine during the COVID-19 pandemic and provides context for why this was vital to facilitate treatment when face-to-face consultations were difficult. Van de Kerkhof weighs the benefits and drawbacks of the use of photos and video conferencing, with a focus on privacy, and equipment and internet accessibility as barriers. Van de Kerkhof also looks at where telemedicine can be successfully implemented, noting scenarios where face-to-face consultation is still required to effectively treat a patient. This interview concludes with a look at the future applications of telemedicine, considering its use in conjunction with typical consultations and the patient experience.
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content